Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
Novo Nordisk A/S - share repurchase programme
February 16, 2023 09:57 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 16 February 2023 – On 1 February 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
February 14, 2023 06:56 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 14 February 2023 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
February 10, 2023 06:36 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 10 February 2023 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...
Heartseed and Novo Nordisk announce first patient dosed in clinical study with HS-001 – a cell therapy designed to restore heart function in people with advanced heart failure
February 10, 2023 02:00 ET
|
Novo Nordisk A/S
HS-001 consists of clusters of purified heart muscle cells derived from induced pluripotent stem cells (iPSCs). Clinical phase 1/2 study (LAPiS Study) will enrol 10 patients with advanced heart...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
February 08, 2023 05:04 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 8 February 2023 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...
Novo Nordisk A/S - share repurchase programme
February 07, 2023 14:40 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 07 February 2023 – On 1 February 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
February 07, 2023 07:37 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 7 February 2023 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...
Trading in Novo Nordisk shares by board members, executives and associated persons
February 03, 2023 10:47 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 3 February 2023 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...
Trading in Novo Nordisk shares by board members, executives and associated persons
February 02, 2023 13:57 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 2 February 2023 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...
Novo Nordisk files annual report with the SEC
February 01, 2023 08:20 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 1 February 2023 – Novo Nordisk A/S has filed its Annual Report 2022 on Form 20-F for the financial year 2022 with the US Securities and Exchange Commission (SEC), incorporating by...